Dorman Products (DORM) opened 2026 earnings season with Q1 numbers set against a recent run of steady results, including Q4 2025 revenue of US$537.9 million and basic EPS of US$0.38 on net income of US$11.6 million. Over the last six reported quarters, revenue has ranged between US$503.8 million and US$543.7 million while quarterly basic EPS has moved from US$1.77 to US$2.50, framing a business that has been consistently profitable. With a trailing 12 month net profit margin of 9.6% and earnings growth in the data, the latest figures provide a view of how efficiently sales are being turned into profit.
See our full analysis for Dorman Products.With the headline figures on the table, the next step is to weigh these results against the most common market narratives around Dorman Products to see which stories line up with the data and which ones start to look less convincing.
See what the community is saying about Dorman Products
Bulls point to steady margins and recurring demand, so if you want to see how that full story is laid out, 🐂 Dorman Products Bull Case
Skeptics focus on EV and tariff risks, and the DCF gap adds context to that caution, so it is worth seeing how the bearish side frames it in detail 🐻 Dorman Products Bear Case
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Dorman Products on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
If the mixed signals in the narratives leave you undecided, it is worth checking the numbers yourself and deciding quickly where you stand. To see what optimism in the data looks like in detail, take a closer look at the 3 key rewards
Dorman’s more moderate 5.4% revenue growth versus the 11.2% US market reference and a DCF value below the current share price highlight valuation tension.
If that valuation gap worries you, it is worth quickly checking whether other companies with stronger pricing or growth profiles look more compelling through the 51 high quality undervalued stocks
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com